Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway

Oncotarget. 2014 Apr 30;5(8):2077-84. doi: 10.18632/oncotarget.1786.

Abstract

The presence and level of circulating galectin-3 (Gal-3), a member of the galectin family, is associated with diverse diseases ranging from heart failure, immune disorders to cancer metastasis and serves as a biomarker of diagnosis and treatment response. However, the mechanisms by which exogenous Gal-3 affects pathobiology events remain elusive. In the current study, we found that exogenous Gal-3 slightly delays, while prolonging tyrosine phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) in HeLa cells through a calcium-sensitive and PKC-dependent signaling pathway. The activation was dependent on the sugar-binding properties of Gal-3, since the antagonist lactose could inhibit it. The sugar-binding motif of Gal-3 was required for the activation of ERK1/2. The activation of ERK1/2 was necessary for the initiation and induction of cell migration associated with the phosphorylation of paxillin. All the results presented in this study suggest a novel calcium-sensitive and PKC-dependent pathway through which circulating Gal-3 promotes cell migration and activating the ERK1/2. Taken together, the data depicted here propose a biological function and a target for the diseases' associated circulating Gal-3.

MeSH terms

  • Blotting, Western
  • Cell Movement / physiology*
  • Enzyme Activation / physiology
  • Galectin 3 / metabolism*
  • HeLa Cells
  • Humans
  • MAP Kinase Signaling System / physiology*
  • RNA, Small Interfering / genetics
  • Transfection

Substances

  • Galectin 3
  • RNA, Small Interfering